Psychedelics

MindMed Announces C$19.5 Million Bought Deal Private Placement Offering

MindMed raises CAD$19.5 million selling units at CAD$3.25.

TSI EDITOR | 03/08/2021

---

MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the Launch of PsyAI™

MagicMed Industries announces an R&D partnership for the development of PsyAI(TM), a an AI-based tool to "modernize psychedelic medicine."

TSI EDITOR | 2021-03-04

---

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

This potential treatment opportunity was confirmed by the company's bioinformatics platform, PsyCollage

TSI EDITOR | 2021-03-04

---

atai Life Sciences Announces the Closing of its $157 Million Series D Financing Round

ATAI announces closing its Series D financing round, raising $157 million.

TSI EDITOR | 2021-03-03

---

​​​​​​​MINDCURE (CSE: MCUR | OTCQB: MCURF) Announces Manufacturing of Synthetic Ibogaine to be Used in Company's Clinical Research

The Company expects to have ibogaine manufactured and in use for research by Q4.

TSI EDITOR | 2021-03-03

---

MINDCURE Completes Its Initial Strategic Equity Investment in ATMA, Canada's First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

MINDCURE makes a CAD$500,000 strategic investment in ATMA Journey Centers, an Alberta-based psychedelics-assisted mental health clinic.

TSI EDITOR | 2021-03-02

---

MINDCURE (CSE: MCUR | OTCQB MCURF) Completes Its Initial Strategic Equity Investment in ATMA, Canada’s First Commercial Provider of Legal, Psychedelic-Assisted, Therapy Utilizing Psilocybin

The completed equity investment strengthens ties between MINDCURE and ATMA

TSI EDITOR | 2021-03-02

---

Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

Mydecine exports dried psilocybin mushrooms from Jamaica to Canada.

TSI EDITOR | 2021-03-01

---

Novamind Reports Company Highlights and Strong Revenue Growth in Fiscal Second Quarter

Novamind reports rising revenues and cash on hand of CAD$10 million.

TSI EDITOR | 2021-03-01

---

Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering

With its (upsized) $82.875 million dollar financing, Field Trip establishes itself as one of the industry leaders in the psychedelics space.

TSI EDITOR | 2021-02-26

---

• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• ...
• 25
• Next